[{"NetIncomeLoss_1_Q2_USD":-42571000.0,"AssetsCurrent_0_Q2_USD":203327000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":6000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1280000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-32190000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":29740000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":172000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":13.48,"OperatingLeaseExpense_2_Q2_USD":2596000.0,"OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_2_Q2_USD":0.0,"CommitmentsAndContingencies_0_Q2_USD":null,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":1733000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":43004000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":43861000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":7768000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":17311000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":17.91,"OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax_1_Q2_USD":0.0,"AccountsReceivableGrossCurrent_0_Q2_USD":467000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":7438000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":7438000.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_2_Q2_shares":172000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":34000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":385000.0,"CommonStockSharesAuthorized_0_Q2_shares":300000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":153000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":10.65,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":35.77,"OperatingLeaseRightOfUseAsset_0_Q2_USD":53157000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":107000.0,"Assets_0_Q2_USD":407865000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":94366000.0,"IncreaseDecreaseInDeferredLiabilities_1_Q2_USD":800000.0,"CommonStockSharesIssued_0_Q2_shares":44776000.0,"LeaseAndRentalExpense_1_Q2_USD":2100000.0,"LeaseAndRentalExpense_2_Q2_USD":4100000.0,"MarketableSecuritiesCurrent_0_Q2_USD":61684000.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_1_Q2_shares":160000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":8000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.017,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.009,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":64668000.0,"GoodwillPeriodIncreaseDecrease_1_Q2_USD":3900000.0,"CommonStockValue_0_Q2_USD":4000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-741000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-741000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q2_USD":61685000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-39000.0,"LettersOfCreditOutstandingAmount_0_Q2_USD":1800000.0,"AssetsFairValueDisclosure_0_Q2_USD":229832000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":84000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":1722000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":1264000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":13.48,"ResearchAndDevelopmentExpense_1_Q2_USD":22787000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-106000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":35659000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":21396000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q2_USD":19557000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":24000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":1768000.0,"Liabilities_0_Q2_USD":111136000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":505168000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":37147000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":135466000.0,"OtherAssetsNoncurrent_0_Q2_USD":5349000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":422000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":842000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":5610000.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":3489000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-42464000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-79625000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":11269000.0,"FinancialLiabilitiesFairValueDisclosure_0_Q2_USD":33830000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":73615000.0,"RestrictedCash_0_Q2_USD":2074000.0,"EquityMethodInvestments_0_Q2_USD":9972000.0,"OperatingIncomeLoss_2_Q2_USD":-80421000.0,"OperatingIncomeLoss_1_Q2_USD":-43273000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q2_shares":1200000.0,"AccountsPayableCurrent_0_Q2_USD":9221000.0,"LiabilitiesCurrent_0_Q2_USD":23770000.0,"MarketableSecuritiesNoncurrent_0_Q2_USD":32682000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_0_Q2_USD":61684000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":44021000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":43176000.0,"EquityMethodInvestmentRealizedGainLossOnDisposal_2_Q2_USD":7227000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":137540000.0,"GainLossOnDispositionOfAssets1_1_Q2_USD":7227000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-55513000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":99000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":137000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3595000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_2_Q2_USD":267000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-43312000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-80527000.0,"GainLossOnDispositionOfAssets1_2_Q2_USD":7227000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":5710000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":135466000.0,"DeferredIncomeTaxesAndTaxCredits_2_Q2_USD":-741000.0,"NetIncomeLoss_2_Q2_USD":-79786000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":19359000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":13672000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":4780000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q2_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_2_Q2_USD":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":129000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":15635000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":26854000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":236000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_0_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":29740000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.071,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.21,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":63404000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":321000.0,"Goodwill_0_Q2_USD":18541000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":9000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":107000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":161000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.97,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.86,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":-3956000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":845000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3280000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":21936000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":144000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":29100000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3595000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":6073000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":407865000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":6.23,"PreferredStockValue_0_Q2_USD":null,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":28118000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":15.66,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":2515000.0,"ProfitLoss_2_Q2_USD":-79786000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":48484000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":754000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":744000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":2577000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":1733000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":6414000.0,"InvestmentsFairValueDisclosure_0_Q2_USD":94366000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":105328000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":1733000.0,"RestrictedCashNoncurrent_0_Q2_USD":2074000.0,"CommonStockSharesOutstanding_0_Q2_shares":44776000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":205000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-51960000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-208615000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":2385000.0,"VariableLeaseCost_1_Q2_USD":600000.0,"VariableLeaseCost_2_Q2_USD":1200000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":6414000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":6000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":94363000.0,"StockholdersEquity_0_Q2_USD":296729000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-95000.0,"Ticker":"KDNY","CIK":"1435049","name":"CHINOOK THERAPEUTICS, INC.","OfficialName":"Chinook Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"858364832.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210812"}]